Pinpoint Asset Management (Singapore)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,000
Closed -$2.56M 158
2025
Q3
$2.56M Hold
20,000
0.46% 33
2025
Q2
$2.42M Buy
+20,000
New +$2.25M 0.42% 36

Other funds holding NVS

Pinpoint Asset Management (Singapore)'s NVS Position: Q4 2025 in Review

Pinpoint Asset Management (Singapore) sold out of Novartis (NVS) in Q4 2025, closing a stake of 20,000 shares — an estimated $2.56M sold.

Pinpoint Asset Management (Singapore) first reported a position in NVS in Q2 2025 and held it in 2 quarters. The position peaked at $2.56M in Q3 2025. 1,514 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • Pinpoint Asset Management (Singapore) reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • Pinpoint Asset Management (Singapore) sold 20,000 Novartis shares in Q4 2025, an estimated $2.56M.
  • Pinpoint Asset Management (Singapore) first reported a position in Novartis in Q2 2025 and held it in 2 quarters.
  • Pinpoint Asset Management (Singapore)'s Novartis position peaked at $2.56M in Q3 2025.
  • 1,514 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Pinpoint Asset Management (Singapore)'s 13F filing for Q4 2025, filed 13 Feb 2026.